Back to HALO
State of Alaska, Department of Revenue → HALO
State of Alaska, Department of Revenue HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$809K
Q3 2026
Peak value
$13.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $921K |
| Q3 2025 | $3.5M |
| Q4 2025 | $778K |
| Q4 2025 | $3.2M |
| Q4 2025 | $493K |
| Q1 2026 | $754K |
| Q1 2026 | $8.9M |
| Q1 2026 | $473K |
| Q2 2026 | $909K |
| Q2 2026 | $9.7M |
| Q2 2026 | $574K |
| Q3 2026 | $1.2M |
| Q3 2026 | $13.6M |
| Q3 2026 | $809K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $809K | 7.3K | — | — |
| Q3 2026 | $13.6M | 123.5K | — | — |
| Q3 2026 | $1.2M | 10.8K | — | — |
| Q2 2026 | $574K | 7.3K | — | — |
| Q2 2026 | $9.7M | 123.5K | — | — |
| Q2 2026 | $909K | 11.6K | — | — |
| Q1 2026 | $473K | 7.3K | — | — |
| Q1 2026 | $8.9M | 138.0K | — | — |
| Q1 2026 | $754K | 11.7K | — | — |
| Q4 2025 | $493K | 7.3K | — | — |
| Q4 2025 | $3.2M | 48.0K | — | — |
| Q4 2025 | $778K | 11.6K | — | — |
| Q3 2025 | $3.5M | 48.0K | — | — |
| Q3 2025 | $921K | 12.6K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M